Filing Details

Accession Number:
0000920465-17-000036
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-06 16:02:00
Reporting Period:
2017-03-02
Filing Date:
2017-03-06
Accepted Time:
2017-03-06 16:02:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
920465 La Jolla Pharmaceutical Co LJPC Biological Products, (No Disgnostic Substances) (2836) 330361285
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1663163 Jennifer Carver C/O La Jolla Pharmaceutical Company,
10182 Telesis Court, 6Th Floor
San Diego CA 92121
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-02 400 $34.49 2,900 No 4 P Direct
Common Stock Acquisiton 2017-03-02 300 $34.45 3,200 No 4 P Direct
Common Stock Acquisiton 2017-03-02 300 $34.44 3,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct